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Functional class(FC), six-minute walk distance (6MWD), uric acid(UA),plasma brain natriuretic peptide (BNP), high-sensitive C-reactive 
protein(hs-CRP) and hemodynamic measures(HM) have been used to assess disease severity and prognosis in patients (pts) with 
pulmonary hypertension (PH). Moreover, diastolic pulmonary gradient (DPG) is proposed as a novel HM in the discrimination of pre-
capillary PH from group II PH.
In this single-center prospective study, EvalUation of Pulmonary Hypertension Risk factors AssociaTEd with Survival(EUPHRATES), we 
assessed the prognostic impact of etiology, baseline FC,6MWD,BNP,UA, hs-CRP and HM in 309 pts (F181, age 46,4± 15,4 years) with PH. 
Subgroups were Idiopathic Pulmonary Arterial Hypertension (IPAH) (n=53) PAH associated with Congenital Heart Disease (APAH-CHD) 
(n=131), other subgroups of PAH (n=16), out-of proportion PH(n=12), group III (n=39) and group IV (n=58) PH. Pulmonary arterial systolic 
and mean pressures were 92,5+31 and 57,2+22,3 mmHg, and mean pulmonary and systemic vascular resistance (PVR,SVR) and PVR/
SVR ratio were10,8±3,7WU, 22+2.5WU and 0,48±0,6, respectively. Mean follow-up was 32±22 months.The DPG showed high correlations 
to transpulmonary gradient (r=0,89,p<0,05) and PVR (r=0,69,p<0,05). 6MWD correlated with FC(r=0,69, p<0,05) but not with DPG, 
cardiac index, PVR or PVR/SVR. The 1, 3 and 5-year survival were 90%, 83% and 60%, respectively. Age and sex were not associated 
with survival (p=NS).The difference between survival curves of FCII and III pts disappeared after 3rd year(p=NS). FC IV vs II (p<0,05) and 
III(p<0,001) in overall PH pts and FC IV vs III (p<0,001) in group I PH were associated with a higher mortality. The 3rd vs 1st tertile of BNP 
were associated with a higher mortality in group I and overall PH pts (p7WU (AUC:0,66; 95% CI:0,58-0,73, p=0,0025) and PVR/SVR >0,60 
(AUC:0,64; 95% CI: 0,57-0,7, p< 0,01) predicted a higher mortality.
In conclusion IPAH etiology, baseline FC, UA, BNP, PVR and PVR/SVR, but not age, sex, baseline hs-CRP, 6MWD and DPG, seem to 
predict survival in pts with PH.
